Questions and Answers On Nanotechnologies: (See Also IP/08/947)
Questions and Answers On Nanotechnologies: (See Also IP/08/947)
Questions and Answers On Nanotechnologies: (See Also IP/08/947)
2
How is the Commission promoting innovation on nanotechnologies in
Europe?
The EU innovation strategy, programmes and activities all apply to nanotechnologies
and nanomaterials. The Competitiveness and Innovation Framework Programme
(CIP) aims to boost the competitiveness of European enterprises. With small and
medium-sized enterprises (SMEs) as its main target, the programme will support
innovation activities (including eco-innovation), provide better access to finance and
deliver business support services in the regions. It will encourage a better take-up
and use of information and communications technologies (ICT) and help to develop
the information society. It will also promote the increased use of renewable energies
and energy efficiency.
What are the potential risks of nanomaterials to human health and the
environment?
Because nanomaterials exhibit novel properties, they may expose humans and the
environment to new risks. To identify the potential risks created by nanomaterials in
specific applications, the Commission is relying on advice from the Scientific
Committees and Panels of the European Community.
In its 2006 opinion, the Scientific Committee for Emerging and Newly Identified
Health Risks (SCENIHR) stated that although the existing toxicological and
ecotoxicological methods are appropriate to assess many of the hazards associated
with the products and processes involving nanoparticles, they may not be sufficient
to address all the hazards. Current risk assessment procedures therefore need to be
modified to take account of nanoparticles. The SCENIHR also identified the main
gaps in the knowledge necessary for risk assessment.
How are the potential risks of nanomaterials to human health and the
environment being managed?
European legislation obliges manufacturers and importers to ensure the safety of all
products they put on the market. When new scientific evidence comes to light, the
Commission and EU Agencies will begin by reviewing the current documents that
support implementation, such as implementing legislation, standards and technical
guidance, to assess their applicability and appropriateness for nanomaterials.
The Commission is funding research on the assessment of the potential impact of
evolving nanotechnology applications. Increased emphasis is being placed on these
activities under the Commission's new 7th Framework Programme. The EU is
playing a leading role in the world in investing in research on safety. Other parties,
including various EU Institutions, Member States, industry (including through the
European Technology Platforms), research organizations and universities are also
contributing to these research activities. Cooperation activities at the international
level include the OECD Working Party on Manufactured Nanomaterials, which
assesses testing guidelines to take into account specificities of nanomaterials, and
the development of standards in ISO and CEN.
3
How are nanotechnologies and products of nanotechnologies
regulated in the EU?
Most EU legislation addresses products but does not usually address specific
technology used for their production. Although there are no provisions in EU
legislation that refer explicitly to nanomaterials, existing legislation on chemicals (e.g.
REACH), worker and environmental protection as well as product-specific legislation
on medical devices, medicinal products, food, feed, cosmetics, plant protection
products, biocides, aerosol dispensers, cars and other products covers in principle
the potential health, safety and environmental risks in relation to nanomaterials.
Current legislation may however have to be modified as regards thresholds used in
some legislation, for example, as new information on nanomaterials becomes
available. The Commission and the relevant EU Agencies have examined and will
continue to examine the applicability and appropriateness of documents supporting
implementation of legislation (e.g. standards, technical guidance documents) to take
account of the special properties of existing and future nanomaterials.
4
Is there cooperation in research with countries outside the EU?
The 7th Framework Programme is open to researchers outside the EU, and partners
in "international cooperation partner countries" may receive EC funding. In addition,
the Commission has been active in pursuing specific collaborations, such as in
safety research with the US, and materials science with India. The Commission also
seeks international policy cooperation, with the aim of addressing issues of mutual
benefit. The third meeting promoting an international dialogue on nanotechnology
was hosted by the EU in March 2008.